| 6/3/2022 |
HFD Offers Engine achieves 100% approval for patients in |
Globe Newswire |
Bakersfield, CA, June 03, 2022 (GLOBE NEWSWIRE) -- Healthcare Finance Direct (HFD), the leading provider of patient finance solutions for elective healthcare procedures, announced that they are able to approve 100 percent of patients in need of personalized payment options. HFD's Offers Engine, a proprietary technology built on AI-powered algorithms, allows HFD to provide patients with the finance solutions they need, regardless of their credit score.The HFD Offers Engine ... |
| 4/30/2022 |
Healthcare Providers able to offer 100% Approval Patient Finance Solutions with Healthcare Finance Direct |
forextv.com |
... time plans for every patientBakersfield, Calif., April 29, 2022 (GLOBE NEWSWIRE) — Healthcare Finance Direct (HFD), the leading pay-over-time solutions provider for the elective healthcare industry, enables providers to offer a patient finance offering with a 100% patient approval rate. Over the past 13 years, HFD’s product has consistently allowed providers to shift their patient conversations from cost to affordability, which in turn helps to schedule ... |
| 4/29/2022 |
Healthcare Providers able to offer 100% Approval Patient Finance Solutions with Healthcare ... |
biomedreports.com |
TweetBakersfield, Calif., April 29, 2022 (GLOBE NEWSWIRE)Bakersfield, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Healthcare Finance Direct (HFD), the leading pay-over-time solutions provider for the elective healthcare industry, enables providers to offer a patient finance offering with a 100% patient approval rate. Over the past 13 years, HFD’s product has consistently allowed providers to shift their patient conversations from cost to affordability, which in turn helps ... |
| 4/29/2022 |
Healthcare Providers able to offer 100% Approval Patient Finance Solutions with Healthcare ... | News | bakersfield.com |
bakersfield.com |
Bakersfield, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Healthcare Finance Direct (HFD), the leading pay-over-time solutions provider for the elective healthcare industry, enables providers to offer a patient finance offering with a 100% patient approval rate. Over the past 13 years, HFD’s product has consistently allowed providers to shift their patient conversations from cost to affordability, which in turn helps to schedule more patient treatments, improving patient health ... |
| 4/4/2022 |
Transplant wait lists and patient finances |
blogspot.com |
Here's a disturbing commentary on how the regulation of transplant centers interacts with patient finances and the decision of who to put on transplant wait lists. The authors suggest extending to all organs the financial coverage that Medicare currently gives to kidney transplants.Viewpoint March 31, 2022Medical Need, Financial Resources, and Transplant Accessibility by Sharad I. Wadhwani, MD, MPH1; Jennifer C. Lai, MD, MBA1; Laura M. Gottlieb, MD, MPH ... |
| 3/24/2022 |
HFD Launches Expanded White Labeling Functionality |
forextv.com |
... today an upcoming product release that will allow providers and industry partners the ability to white label HFD’s platform. The release, planned for April 2022, will enable providers to offer a more seamless patient finance experience, by combining their practice’s branding with HFD’s category-leading platform and finance products.“White labeling is one of our providers’ most commonly requested features,” said Tyler Johnson, CEO of ... |
| 3/24/2022 |
HFD Launches Expanded White Labeling Functionality |
biomedreports.com |
... today an upcoming product release that will allow providers and industry partners the ability to white label HFD’s platform. The release, planned for April 2022, will enable providers to offer a more seamless patient finance experience, by combining their practice’s branding with HFD’s category-leading platform and finance products.“White labeling is one of our providers’ most commonly requested features,” said Tyler Johnson, CEO of ... |
| 3/24/2022 |
HFD Launches Expanded White Labeling Functionality |
Globe Newswire |
... today an upcoming product release that will allow providers and industry partners the ability to white label HFD’s platform. The release, planned for April 2022, will enable providers to offer a more seamless patient finance experience, by combining their practice’s branding with HFD’s category-leading platform and finance products.“White labeling is one of our providers’ most commonly requested features,” said Tyler Johnson, CEO of ... |
| 3/15/2022 |
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments |
gayaherald.com |
... after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finance s. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.Some of the key takeaways from the Postoperative ... |
| 3/15/2022 |
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments |
jharkhandmagazine.org |
... after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finance s. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.Some of the key takeaways from the Postoperative ... |
| 3/15/2022 |
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments |
jammujournal.com |
... after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finance s. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.Some of the key takeaways from the Postoperative ... |
| 3/14/2022 |
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments |
blogspot.com |
... after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finance s. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.Some of the key takeaways from the Postoperative ... |
| 3/14/2022 |
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments |
thenewsbird.com |
... after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finance s. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.Some of the key takeaways from the Postoperative ... |
| 3/14/2022 |
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments |
atlantanews-online.com |
... after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finance s. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.Some of the key takeaways from the Postoperative ... |
| 3/14/2022 |
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments |
bostonnewsdesk.com |
... after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finance s. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.Some of the key takeaways from the Postoperative ... |
| 3/14/2022 |
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments |
columbusnewsonline.com |
... after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finance s. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.Some of the key takeaways from the Postoperative ... |
| 3/14/2022 |
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments |
desmoinesnewsdesk.com |
... after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finance s. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.Some of the key takeaways from the Postoperative ... |
| 3/14/2022 |
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments |
coloradonewsdesk.com |
... after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finance s. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.Some of the key takeaways from the Postoperative ... |
| 3/14/2022 |
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments |
connecticutchronicle.com |
... after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finance s. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.Some of the key takeaways from the Postoperative ... |
| 3/14/2022 |
Postoperative Pain Pipeline Drugs & Key Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments |
batonrougenewsreporter.com |
... after surgery or any other operative procedure, which also leads to an increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finance s. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.Some of the key takeaways from the Postoperative ... |